Electrophysiological Findings in Patients Treated with Indomethacin
As an increasing number of drugs are being designed which act with an unknown way to different parts of the metabolism of the human body, one must expect an increase of adverse reactions, especially of the sensitive sensory organs. Indomethacin: (1- (p-chlorobenzoyl) — r methoxy-2 methyl indole-3 acetic acid) Trade name: Indocid (Merck, Sharpe and Dohme), is a synthetic non-steroidal, chemical. It has been widely acclaimed for its anti-inflammatory, anti-pyretic and analgesic properties. It has been effective in the treatment of patients with rheumatoid disorders and fibrositis (Boardman and Hart, 1964; Yamada, 1970). Its anti-inflammatory action is less than that of the steroids (Perkins and McFaul, 1965). The daily dose is up to 200 mg. usually about 100 mg.
KeywordsImplicit Time Bioelectrical Activity Electrophysiological Finding Ocular Side Effect White Light Stimulus
Unable to display preview. Download preview PDF.
- BURNS, C.A. 1966. Invest. Ophthal., 5, 325.Google Scholar
- BOARDMAN, P.L. and D. HART. 1964. J. Franco-Italo-Suisse de Rheumatologie Sept.-Oct.Google Scholar
- ELLIS, P.P. 1970. In: Leopold. Symposium on Ocular Pharmacology and therapeutics. C.V. Mosby Co., St. Louis, 58.Google Scholar
- PALIMERIS, G., P. VELISSAROPOULOS and N. MANGOURITSAS. 1970. Bull. Hel. Ophthal. Soc., 38, 417.Google Scholar
- PERKINS, E.S. and P. McFAUL. 1965. Trans. ophthal. Soc. U.K., 85, 53.Google Scholar
- YAMADA, S. 1970. Jap. J. Clin. Ophthal., 24, 913.Google Scholar
- VELISSAROPOULOS, P., G. PALIMERIS and D. ANDREANOS. 1971. Arch. Ophthal., 131, 4, 305.Google Scholar